Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2000
08/31/2000DE19908184A1 Verfahren zur Herstellung wässriger Dispersionen von Copolymerisaten aus hydrophilen und hydrophoben Monomeren sowie daraus erhältliche Copolymerisate und deren Anwendungen A process for the preparation of aqueous dispersions of copolymers of hydrophilic and hydrophobic monomers as well as copolymers obtainable therefrom and their applications
08/31/2000DE19907552A1 New stable polyelectrolyte capsules of controllable permeability, prepared by coating template particles, useful e.g. for controlled drug release
08/31/2000CA2689696A1 Microemulsions with adsorbed macromolecules and microparticles
08/31/2000CA2366951A1 Methods and compositions for altering mucus secretion
08/31/2000CA2366747A1 Controlled release formulation for treating copd
08/31/2000CA2366712A1 A means for the prophylactic and therapeutic treatment of streptococcal infections
08/31/2000CA2366688A1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens
08/31/2000CA2364849A1 Compounds and compositions for delivering active agents
08/31/2000CA2364780A1 Enteral sorbefacients
08/31/2000CA2363168A1 Controlled release bupropion formulation
08/31/2000CA2363126A1 Rapidly-soluble compositions
08/31/2000CA2363048A1 Treatment of trauma
08/31/2000CA2363036A1 Composition for the treatment of psoriasis
08/31/2000CA2326690A1 The process for manufacturing topical ophthalmic preparations without systemic effects
08/30/2000EP1031585A2 Method of preparation of aqueous dispersions from copolymers of hydrophile and hydrophobe monomers, these copolymers and their uses
08/30/2000EP1031578A2 High purity albumin production by a multistep process
08/30/2000EP1031353A1 Antimycotic compositions
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1031346A1 Noninvasive vaccination through the skin
08/30/2000EP1031345A1 Gel preparation containing polystyrene-sulfonates
08/30/2000EP1030734A1 Encapsulate of active material in alginate matrix
08/30/2000EP1030689A1 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
08/30/2000EP1030688A1 Method for decreasing self-association of polypeptides
08/30/2000EP1030687A2 Cosmetic or dermopharmaceutical composition in the form of beads and methods for preparing same
08/30/2000EP1030686A2 Lyophilizate of lipid complex of water insoluble porphyrins
08/30/2000EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
08/30/2000EP1030676A1 Bonding of cartilaginous matrices using isolated chondrocytes
08/30/2000EP1030668A1 Penetration enhancing and irritation reducing systems
08/30/2000EP1030664A1 Pharmaceutical compositions containing zafirlukast
08/30/2000EP1030662A2 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/30/2000EP1030660A1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof
08/30/2000EP1030657A1 Prolamin-plant polar lipid combination, preparation method and applications
08/30/2000EP1030656A1 Administering active substances by using the capsid produced out of the polyoma virus vp1 protein
08/30/2000EP1030655A1 Low temperature coatings
08/30/2000EP1030654A1 Omeprazole formulation
08/30/2000EP1030653A1 Dinitroaniline liposomal formulations and processes for their preparation
08/30/2000EP1030652A1 Production of multivesicular liposomes
08/30/2000EP1030651A1 Novel oral dosage form for carvedilol
08/30/2000EP1030629A1 Pessary with medicated cartridge
08/30/2000EP1030560A1 Method and devices for transdermal delivery of lithium
08/30/2000EP1030547A1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
08/30/2000EP0998251A4 Compositions and methods for inhibiting photoaging of skin
08/30/2000EP0892637A4 Electrostatically charged nasal application device and process
08/30/2000EP0831912A4 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
08/30/2000EP0742789B1 Pharmaceutically active compounds and liposomes, and methods of use therof
08/30/2000EP0730493B1 Use of a polymer material based on modified hydrocolloids as encapsulating material
08/30/2000EP0711148B1 Biphasic multilamellar lipid vesicles
08/30/2000EP0642348B1 Antibiotic cryptdin peptides and methods of their use
08/30/2000EP0633755B1 Systems for cells implants
08/30/2000EP0573605B1 Preparation of factor ix
08/30/2000CN2393539Y Apparatus for packing Chinese medicinal pills by vacuum wax shells
08/30/2000CN1265045A Process for selection of particles of preselected size from particulate pharmaceutical product
08/30/2000CN1265037A Soya extract, process for its prepn. and pharmaceutical compsn.
08/30/2000CN1265035A Method for inhibiting bone resorption
08/30/2000CN1265031A Osmotic delivery system with semipermeable plug
08/30/2000CN1265030A Osmotic delivery system flow modulator appts.
08/30/2000CN1265029A Pharmaceutical compsn. having two coating layers
08/30/2000CN1264712A Method for preparing copolymer water dispersing body by hydrophilous and hydrophobic monomer, and obtained copolymer therefrom and application
08/30/2000CN1264710A Modification and preparation of human interleukin 11
08/30/2000CN1264708A Total safflower yellow and its preparing process and application
08/30/2000CN1264600A Definition medium and its application
08/30/2000CN1264596A Polypeptide medicine as oral spray
08/30/2000CN1264594A Labor-inducing oral liquid and preparing process thereof
08/30/2000CN1264593A Medicine for treating dermatopathy and preparing process thereof
08/30/2000CN1264592A Medicine for treating ichthyosis and preparing process thereof
08/30/2000CN1264591A Medicine for treating psoriasis and preparing process thereof
08/30/2000CN1264590A Medicine for treating leukoderma and preparing process thereof
08/30/2000CN1264589A Medicine for treating leukoderma and preparing process
08/30/2000CN1264583A Active aloe powder and preparing process thereof
08/30/2000CN1264579A Single Chinese medicine loaded quantitatively in filter bag and its preparing process
08/30/2000CN1264578A Fruit jelly medicine
08/30/2000CN1055863C Health-care defatting products and its prepn. thereof
08/30/2000CN1055857C Chinese drugs for darkening hair and its prepn. method
08/30/2000CN1055854C Bone knitting powder
08/30/2000CN1055847C Medicine for curing deficiency of liver and kidney and its prodn. method
08/30/2000CN1055846C Pharynx and larynex health care products and its prodn. tech.
08/30/2000CN1055843C Method for prepn. of medicine for treating aplastic anemia
08/30/2000CN1055841C External adhesive plaster for treating infantile pneumonia and prepn. method for same external adhesive plaster
08/30/2000CN1055839C Prepn. for treating cancer and its preparing process
08/30/2000CN1055838C Chinese herbal medicinal bag for infantile diarrhea and malnutrition
08/30/2000CN1055837C Chinese medicine for treating blood vessel dementia
08/30/2000CN1055834C Quick results detumescence pain stop paste and preparing process
08/30/2000CN1055832C Capsule of cartilage powder of shark and prepn. thereof
08/30/2000CN1055827C Sustained-release matrices for dental application
08/29/2000US6111098 Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
08/29/2000US6110973 Methods for treating obesity and weight gain using optically pure (-)-bupropion
08/29/2000US6110926 Storage stable aqueous solution of naloxone hydrochloride mixed with a polyhydric alcohol; for opioid addiction testing
08/29/2000US6110921 Administering to mammal a sustained-release microparticle comprising antipsychotic agent in biodegradable polymer matrix
08/29/2000US6110916 For transfection/drug delivery of macromolecules and other compounds into cells
08/29/2000US6110905 Long-acting oxytetracycline composition
08/29/2000US6110902 Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
08/29/2000US6110745 Contacting nucleic acid with solution of non-cationic and cationic lipids, removing aqueous portion, removing organic solvent portion to form complex in the form of a film, and hydrating complex to form particle
08/29/2000US6110506 Synthesizing a dihydroxy aluminum sodium carbonate, isolating the undried dihydroxyaluminum sodium carbonate and mixing with water and a polyol selected from glycerol, mannitol, maltodextrin and frusctose, forming a suspension, then drying
08/29/2000US6110505 Translucent antacid suspension containing co-dried dihydroxy aluminum sodium carbonate
08/29/2000US6110504 A crystalloid solution consisting of dissolved salts comprising sodium chloride, potassium chloride, calcium chloride, magnesium chloride and organic acid selected from lactate, acetate, pyruvate, gluconate, succinate, and glucose
08/29/2000US6110503 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
08/29/2000US6110502 Method for producing water dispersible sterol formulations
08/29/2000US6110501 Seeded microcapsules for use in tablets, pharmaceutical agents and nutritional compounds
08/29/2000US6110500 Coated tablet with long term parabolic and zero-order release kinetics
08/29/2000US6110499 Phenytoin therapy